Yardley DA - Search Results

1

De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry.

Tripathy D, Brufsky A, Cobleigh M, Jahanzeb M, Kaufman PA, Mason G, O'Shaughnessy J, Rugo HS, Swain SM, Yardley DA, Chu L, Li H, Antao V, Hurvitz SA. Tripathy D, et al. Among authors: yardley da. Oncologist. 2020 Feb;25(2):e214-e222. doi: 10.1634/theoncologist.2019-0446. Epub 2019 Oct 14. Oncologist. 2020. PMID: 32043771 Free PMC article.

2

Gemcitabine and taxanes as a new standard of care in breast cancer.

Yardley DA. Yardley DA. Clin Breast Cancer. 2004 Jan;4 Suppl 3:S107-12. doi: 10.3816/cbc.2004.s.003. Clin Breast Cancer. 2004. PMID: 14754467 Review.

3

Phase II trial of trastuzumab followed by weekly paclitaxel/carboplatin as first-line treatment for patients with metastatic breast cancer.

Burris H 3rd, Yardley D, Jones S, Houston G, Broome C, Thompson D, Greco FA, White M, Hainsworth J. Burris H 3rd, et al. J Clin Oncol. 2004 May 1;22(9):1621-9. doi: 10.1200/JCO.2004.08.065. J Clin Oncol. 2004. PMID: 15117984 Clinical Trial.

4

Gemcitabine and docetaxel in metastatic and neoadjuvant treatment of breast cancer.

Yardley DA. Yardley DA. Semin Oncol. 2004 Apr;31(2 Suppl 5):37-44. doi: 10.1053/j.seminoncol.2004.03.026. Semin Oncol. 2004. PMID: 15199531 Review.

5

Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.

Greco FA, Rodriguez GI, Shaffer DW, Hermann R, Litchy S, Yardley DA, Burris HA 3rd, Morrissey LH, Erland JB, Hainsworth JD. Greco FA, et al. Among authors: yardley da. Oncologist. 2004;9(6):644-52. doi: 10.1634/theoncologist.9-6-644. Oncologist. 2004. PMID: 15561808 Free article. Clinical Trial.

6

Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer.

O'Shaughnessy JA, Clark RS, Blum JL, Mennel RG, Snyder D, Ye Z, Liepa AM, Melemed AS, Yardley DA. O'Shaughnessy JA, et al. Among authors: yardley da. Clin Breast Cancer. 2005 Jun;6(2):143-9. doi: 10.3816/CBC.2005.n.016. Clin Breast Cancer. 2005. PMID: 16001992 Clinical Trial.

7

Gemcitabine plus paclitaxel in breast cancer.

Yardley DA. Yardley DA. Semin Oncol. 2005 Aug;32(4 Suppl 6):S14-21. doi: 10.1053/j.seminoncol.2005.06.025. Semin Oncol. 2005. PMID: 16143163 Review.

8

Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: a Minnie Pearl Cancer Research Network Phase II trial.

Hainsworth JD, Yardley DA, Spigel DR, Meluch AA, Rinaldi D, Schnell FM, Greco FA. Hainsworth JD, et al. Among authors: yardley da. Cancer Invest. 2006 Aug-Sep;24(5):469-73. doi: 10.1080/07357900600814060. Cancer Invest. 2006. PMID: 16939953 Clinical Trial.

9

A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.

Yardley DA, Burris HA 3rd, Farley CP, Barton JH, Peacock NW, Spigel DR, Greco FA, Hainsworth JD. Yardley DA, et al. Clin Breast Cancer. 2008 Jun;8(3):242-8. doi: 10.3816/CBC.2008.n.027. Clin Breast Cancer. 2008. PMID: 18650154 Clinical Trial.

10

A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.

Yardley DA, Burris HA 3rd, Simons L, Spigel DR, Greco FA, Barton JH, Shipley D, Drosick D, Hainsworth JD. Yardley DA, et al. Clin Breast Cancer. 2008 Oct;8(5):425-31. doi: 10.3816/CBC.2008.n.051. Clin Breast Cancer. 2008. PMID: 18952556 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters